Interims & Rights Issue-Part2

Costain Group PLC 14 September 2007 PART 2 APPENDIX IV APPENDIX IV PLACING TERMS AND CONDITIONS IMPORTANT INFORMATION FOR PLACEES ONLY MEMBERS OF THE PUBLIC ARE NOT ELIGIBLE TO TAKE PART IN THE PLACING OF THE FULLY PAID RIGHTS IN CONNECTION WITH THE RIGHTS ISSUE. THIS APPENDIX AND THE TERMS AND CONDITIONS SET OUT AND REFERRED TO HEREIN ARE DIRECTED ONLY AT PERSONS SELECTED BY DRESDNER BANK AG, LONDON BRANCH ('DBAG') AND/OR DRESDNER KLEINWORT SECURITIES LIMITED ('DKS') AND/OR ARBUTHNOT SECURITIES LIMITED ('ARBUTHNOT') WHO ARE 'INVESTMENT PROFESSIONALS' AS DESCRIBED IN ARTICLE 19(5) OF THE FINANCIAL SERVICES AND MARKETS 2000 (FINANCIAL PROMOTION) ORDER 2001 (AS AMENDED) (THE 'ORDER'), ARE PERSONS FALLING WITHIN ARTICLE 49(2)(a) TO (d) ('HIGH NET WORTH COMPANIES, UNINCORPORATED ASSOCIATIONS, ETC.') OF THE ORDER OR TO WHOM IT MAY OTHERWISE LAWFULLY BE COMMUNICATED (ALL SUCH PERSONS TOGETHER BEING REFERRED TO AS 'RELEVANT PERSONS'). THIS APPENDIX AND THE TERMS AND CONDITIONS SET OUT HEREIN MUST NOT BE ACTED ON OR RELIED ON BY PERSONS WHO ARE NOT RELEVANT PERSONS. ANY INVESTMENT ACTIVITY TO WHICH THIS APPENDIX AND THE TERMS AND CONDITIONS SET OUT HEREIN RELATES IS AVAILABLE ONLY TO RELEVANT PERSONS AND WILL BE ENGAGED IN ONLY WITH RELEVANT PERSONS. This announcement and the information contained herein are not for publication or distribution, directly or indirectly, to persons in the United States, Canada, France, Japan, Malaysia, New Zealand, South Africa or Switzerland or in or into any other jurisdiction in which such publication or distribution is unlawful (a 'Prohibited Jurisdiction'). This document and the information contained herein are not for publication or distribution, directly or indirectly, to person in a Prohibited Jurisdiction unless permitted pursuant to an exemption under the relevant local law or regulation in any such jurisdiction. Unless otherwise defined in this Appendix, definitions used in this Appendix shall have the same meanings set out in Appendix V. Terms and Conditions of the Placing If a Relevant Person chooses to participate in the placing by DBAG and Arbuthnot of the Fully Paid Rights (as defined below) in connection with the Rights Issue (the 'Placing') by making or accepting an offer for a Placing participation (each such Relevant Person being hereinafter referred to as a 'Placee') it will be deemed to have read and understood this Appendix in its entirety and to be making or accepting such offer on the terms and conditions and to be providing the representations, warranties and acknowledgements contained in this Appendix. In particular, each Placee represents, warrants and acknowledges to each of DBAG and Arbuthnot for themselves and as agents for the Company that it: 1. is, and at the time it agrees to acquire the Fully Paid Rights will be, outside the United States and it will acquire any Fully Paid Rights pursuant to its Placing participation in an 'offshore transaction' in reliance on Regulation S of the Securities Act; or 2. (i) is a qualified institutional buyer ('QIB') (as defined in Rule 144A of the US Securities Act) and (ii) has duly executed a US investor representation letter in the form provided to it (or otherwise agreed by DKS and Arbuthnot) and has delivered the same to Dresdner Kleinwort Securities LLC. The Fully Paid Rights referred to in this announcement have not been and will not be registered under the Securities Act, and may not be offered or sold within the United States absent registration or an exemption from registration. The New Ordinary Shares, the Nil Paid Rights, the Fully Paid Rights and the Provisional Allotment Letters have not been approved or disapproved by the SEC, any state securities commission in the United States or any other US regulatory authority, nor have any of the foregoing authorities passed upon or endorsed the merits of the offering of the New Ordinary Shares, the Nil Paid Rights, the Fully Paid Rights or the Provisional Allotment Letters or the accuracy or adequacy of this document. Any representation to the contrary is a criminal offence in the United States. This announcement and Appendix do not constitute an offer to sell or issue or a solicitation of an offer to buy or subscribe for Fully Paid Rights in any jurisdiction including, without limitation, the United States, Canada, France, Japan, Malaysia, New Zealand, South Africa or Switzerland or any other jurisdiction in which other such offer or solicitation is or may be unlawful. The distribution of this announcement and the Placing and issue of the Fully Paid Rights and/or the New Ordinary Shares in certain jurisdictions may be restricted by law. Persons to whose attention this announcement has been drawn are required by the Company, DKS, DBAG and Arbuthnot to inform themselves about and to observe any such restrictions. Details of the Underwriting Agreement and the Fully Paid Rights Daedalus Projects Limited ('Daedalus') has irrevocably undertaken pursuant to an undertaking dated 29 August 2007 (the 'Irrevocable Undertaking') to, inter alia, the Company, DBAG and Arbuthnot to sell 81,261,941 of the Nil Paid Rights to which it is entitled under the Rights Issue and to apply the net proceeds of such sale in taking up the remainder of its entitlement under the Rights Issue. The Company has today entered into an underwriting agreement (the 'Underwriting Agreement') with, inter alia, DBAG and Arbuthnot under which DKS, as an affiliate of DBAG, and Arbuthnot have agreed to procure persons to acquire the Nil Paid Rights to be sold by Daedalus or the Fully Paid Rights or New Ordinary Shares relating to such rights on the terms and subject to the conditions set out herein. To the extent that DKS and Arbuthnot do not procure persons to take up the Nil Paid Rights or any Fully Paid Rights or New Ordinary Shares relating thereto, DBAG and/or Arbuthnot shall attempt to place them in the Rump and if they fail to do so, DBAG and/or Arbuthnot and/or the sub-underwriters (as the case may be) shall acquire the balance of them in the Stick. Any Rump placing will be made subject to separate terms and conditions announced at the time of such placing. Before implementing the Placing, for administrative reasons DKS will pay up in full the 81,261,941 Nil Paid Rights to be sold by Daedalus (the resulting Fully Paid Rights being the 'Fully Paid Rights'). Placees will therefore acquire Fully Paid Rights in the Placing. The New Ordinary Shares relating to the Fully Paid Rights will, when issued and fully paid, rank in full for all dividends declared after the Record Date and otherwise pari passu in all respects with the Existing Shares. Application for Listing and Admission to Trading Application will be made to the UKLA for admission of the Nil Paid, Rights, the Fully Paid Rights and the New Ordinary Shares to the Official List of the UKLA (the 'Official List') and to the London Stock Exchange for admission to trading of the Nil Paid Rights, the Fully Paid Rights and the New Ordinary Shares on the London Stock Exchange's market for listed securities. It is expected that Admission will take place at 8.00am on 3 October 2007. Principal Terms of the Placing This Appendix gives details of the terms and conditions of, and the mechanics of participation in, the Placing. 1. DBAG (through DKS) and Arbuthnot will arrange the Placing and participation will only be available to persons invited to participate by DBAG and/or DKS and/or Arbuthnot. 2. The price payable per Daedalus Fully Paid Right shall be 27.7857 pence (the 'Placing Price'). Placees will also be required to pay UK stamp duty or stamp duty reserve tax (as appropriate) on the aggregate value of their Placing Commitment at the Placing Price. 3. A Placee's commitment to acquire a fixed number of Fully Paid Rights will be agreed with and confirmed to it orally (the 'Placing Commitment') and a written confirmation (a 'Confirmed Commitment Letter') will be dispatched as soon as possible thereafter. The oral confirmation to the Placee by DKS (as an affiliate of DBAG) or by Arbuthnot (as appropriate) (the 'Oral Confirmation') constitutes an irrevocable, legally binding contractual commitment to either DBAG or Arbuthnot (as appropriate) to acquire a fixed number of Fully Paid Rights allocated to it on the terms and conditions set out in this Appendix (the 'Contract'). No commissions are payable to Placees in respect of their Placing Commitments. A Form of Confirmation will be included with each Confirmed Commitment Letter and this should be completed and returned by fax by 3.00 p.m. on the business day following the giving of the Oral Confirmation. If the Oral Confirmation was given by DKS, the Confirmed Commitment Letter should be completed and returned by fax to Simon Green at DKS. If the Oral Confirmation was given by Arbuthnot, the Confirmed Commitment Letter should be completed and returned by fax to Richard Johnson at Arbuthnot. 4. Following the Oral Confirmation, each Placee will, subject to Admisison, have an immediate, separate, irrevocable and binding obligation, owed to DKS or Arbuthnot (as appropriate) to pay in cleared funds an amount equal to the product of the Placing Price and the number of Fully Paid Rights comprised in its Placing Commitment. Settlement for the Fully Paid Rights is due in cleared funds by 11.00 am on 5 October 2007 or by the Placee ensuring that its CREST account enables delivery of such Fully Paid Rights to be made to it on 8 October 2007 against payment of the settlement price. DBAG, DKS and Arbuthnot shall be entitled to effect the Rights Issue and/or the Placing by such method as they shall in their sole discretion determine. To the fullest extent permissible by law, none of DBAG, DKS or Arbuthnot, any holding company thereof, not any subsidiary, branch or affiliate of any of them (each an 'Affiliate') nor any person acting on behalf of any of them shall have any liability to Placees (or to any other person whether acting on behalf of a Placee or otherwise). In particular, none of DBAG, DKS and Arbuthnot, any Affiliate thereof nor any person acting on their behalf shall have any liability in respect of its conduct of the Rights Issue (including the Placing) or of such alternative method of effecting the Rights Issue and/or the Placing as it may determine. Conditions of the Rights Issue The Placing will not proceed unless all of the conditions to the obligations of DBAG and Arbuthnot under the Underwriting Agreement are satisfied or are waived in accordance with its terms. The obligations of DBAG and Arbuthnot under the Underwriting Agreement are conditional, inter alia, on: 1. the passing of the Resolutions at the Extraordinary General Meeting on the EGM Date (and not, without the prior written consent of DBAG and Arbuthnot, at any adjournment thereof) without any amendment not previously approved in writing by the DBAG and Arbuthnot; 2. none of the warranties given by the Company in the Underwriting Agreement being untrue, inaccurate or misleading at the date of the Underwriting Agreement and there being no change of circumstances such that, if such warranties were to be repeated at any time before Admission by reference to the facts and circumstances then subsisting, any such warranty would be untrue, inaccurate or misleading, in each case in a manner which is material in the context of the Admission or the Rights Issue; 3. there not having occurred or arisen prior to Admission any significant change or new matter as is referred to in section 87G of the FSMA which requires a supplementary prospectus to be published; 4. each condition to enable the Nil Paid Rights and the Fully Paid Rights to be admitted as a participating security (as defined in the Regulations) in CREST (other than Admission) being satisfied on or before the EGM Date; 5. the FSA agreeing to admit the Rights Shares (nil paid and fully paid) to the Official List and the London Stock Exchange agreeing to admit the Rights Shares to trading on its market for listed securities (both subject only to allotment of the Rights Shares) by no later than the EGM Date and Admission occurring at 8.00 a.m. on the first Dealing Day following the EGM Date; 6. the Existing Facilities Agreements remaining in full force and effect between the publication of the Prospectus and Admission, all representations and all warranties repeated or given by the Company under the Facilities Amendment Agreements being, or when given being, correct and accurate in all respects, all conditions precedent to the New Facilities Agreements and the Facilities Amendment Agreements (other than those conditions relating to Admission and the Underwriting Agreement becoming unconditional) having been satisfied or waived in accordance with the terms of such agreements before Admission and the Company having confirmed to DBAG and Arbuthnot (after consulting with the Existing Facilities Agreements and New Facilities Agreements lead arrangers) in writing following the EGM and in any event no later than 5.00 p.m. on the EGM Date that: so far as it is aware (i) there is no reason why (A) all of the conditions precedent to the Facilities Amendment Agreements and the New Facilities Agreements will not be satisfied as at Admission and (B) any representations or warranties required to be given or repeated pursuant to the Facilities Amendment Agreements or the New Facilities Agreements will not be capable of being given or repeated as required by such agreements; and (ii) no fact, matter or circumstance exists which is likely to result in any of the Existing Facilities (as amended and restated by the Facilities Amendment Agreements) or the New Facilities being withdrawn or otherwise not being available for draw-down by the Company in full; and there has been no material breach of the terms of the Existing Facilities Agreements or the Facilities Amendment Agreements which has not been remedied or waived and, so far as it is aware, no fact, matter or circumstance exists which is likely to result in any material breach of the terms of the Existing Facilities Agreements, the Facilities Amendment Agreements or the New Facilities Agreements occurring; 7. each of the Undertakings having been complied with in full before Admission (to the extent that they fall to be complied with before such time); and 8. the UEM Instruction Letter having been duly signed and delivered by UEM and Rood Nominees Limited to DBAG and having not been revoked, in each case before Admission. If (a) the conditions set out in the Underwriting Agreement are not satisfied or (to the extent permitted under the Underwriting Agreement) waived by DBAG and Arbuthnot by the required time (or before such later time and/or date as the Company, DBAG and Arbuthnot may agree) or (b) the Underwriting Agreement is terminated in the circumstances specified below, the Placing and the Rights Issue will lapse and the rights and obligations of the Placees hereunder shall cease and determine at such time and no claim can be made by any Placee in respect thereof. In addition, the obligations of DKS and Arbuthnot under the Placing are conditional on Daedalus complying in full with the terms of the Irrevocable Undertaking. Rights of Termination DBAG and Arbuthnot may, following discussion with the Company where the circumstances permit at any time prior to Admission terminate their respective obligations under the Underwriting Agreement by giving notice to the Company if inter alia: 1. in the opinion of DBAG and Arbuthnot (acting in good faith), the warranties in the Underwriting Agreement are not true and accurate or have become misleading (or would not be true and accurate or would be misleading if they were repeated at any time before Admission) by reference to the facts subsisting at the and in the opinion of DBAG and Arbuthnot (acting in good faith) such breach is material and adverse in the context of Admission or the Rights Issue; or 2. in the opinion of DBAG and Arbuthnot (acting in good faith), there has been a breach by the Company of any of its obligations under the Underwriting Agreement or certain related agreements which is in the opinion of DBAG and Arbuthnot (acting in good faith) material in the context of Admission or the Rights Issue; or 3. in the opinion of DBAG and Arbuthnot (acting in good faith), there has been a material adverse change in the financial or trading position or prospects of the Group as a result of which DBAG and Arbuthnot consider (acting in good faith) it is impracticable or inadvisable to proceed with Admission or the Rights Issue; or 4. any new matter or circumstance arises, and as a result of such matter or circumstance, it is necessary, in the opinion of DBAG and Arbuthnot (acting in good faith), to amend or supplement the Prospectus in the approved terms, in order that the Prospectus will not contain an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein not misleading or in order to ensure the Prospectus complies with the Prospectus Rules, the Companies Act, the FSMA, the Listing Rules and all other statutes and governmental and regulatory authority regulations applicable to the Rights Issue and which, in any case, in the opinion of DBAG and Arbuthnot (acting in good faith) is material and adverse in the context of Admission or the Rights Issue, or 5. any sub-underwriter terminates its sub-underwriting commitment following publication of any supplementary prospectus or the announcement of any intention to publish such a supplementary prospectus; or 6. any press or public announcement concerning the Group or the Rights Issue has been made by or on behalf of the Group which has not been sanctioned by the Underwriters prior to its release (such sanction not to be unreasonably withheld or delayed) and which in the opinion of DBAG and Arbuthnot (acting in good faith) is detrimental to the Group and material and adverse in the context of Admission or the Rights Issue; or 7. in the opinion of DBAG and Arbuthnot (acting in good faith), there has been after today's date: (a) a change in national or international, financial, political, economic or stock market conditions (primary or secondary); or (b) an incident of terrorism, outbreak or escalation of hostilities, war, declaration of martial law or any other calamity or crisis; or (c) a suspension or material limitation in trading of securities generally on any major stock exchange in the United Kingdom; or (d) a change in currency exchange rates or exchange controls in the United Kingdom, or a disruption of settlement systems in the United Kingdom, or a material disruption in commercial banking in the United Kingdom, in each case as would be likely to prejudice materially the success of the Rights Issue. Each Placee agrees with DKS, DBAG and Arbuthnot that the waiver by DBAG and Arbuthnot, or the agreement by DBAG and Arbuthnot to the extension of time for the satisfaction, of any condition of the Underwriting Agreement or the exercise by DBAG and Arbuthnot of their right of termination of the Underwriting Agreement, or any other discretion under such agreement, shall be within the absolute discretion of DBAG and Arbuthnot and that none of DKS, DBAG nor Arbuthnot shall have any liability to any Placee whatsoever in connection with any decision to waive any such condition, agree to any such extension or to exercise or not to exercise any such right or discretion. By participating in the Placing, each Placee agrees that its rights and obligations hereunder terminate only in the circumstances described above and will not be capable of rescission or termination by any Placee. Information for Placees A Prospectus will be published in connection with the Rights Issue and Admission and will be approved by the UKLA. Placees have been sent a placing proof of the draft Prospectus (the 'U Proof'). A Placee may only rely on the information contained in the U Proof in deciding whether or not to participate in the Placing. Each Placee, by accepting a participation in the Placing, agrees that the content of this announcement and the U Proof are exclusively the responsibility of the Company and confirms to DBAG, DKS, Arbuthnot and the Company that it has neither received nor relied on any other information, representation, warranty or statement made by or on behalf of DKS, DBAG or Arbuthnot or any of their respective affiliates or the Company (other than the amount of the relevant placing participation communicated by DKS or Arbuthnot (as appropriate) in the Oral Confirmation), and none of DKS, DBAG, Arbuthnot or any of their respective affiliates or the Company will be liable for the decision of any Placee to accept an invitation to participate in the Placing based on any other information, representation, warranty or statement which the Placee may have obtained or received. Each Placee acknowledges to and agrees with each of DKS, DBAG and Arbuthnot for themselves and as agents for the Company, that it has relied only on the information in the U Proof and this announcement in making its decision to participate in the Placing. Nothing in this paragraph shall exclude the liability of any person for fraudulent misrepresentation. Registration and Settlement Settlement of transactions in the New Ordinary Shares following Admission will take place within CREST, using the DVP system, subject to certain exceptions. DKS, DBAG and Arbuthnot reserve the right to require settlement for and delivery of the Fully Paid Rights to any Placee by such other means as they respectively deem necessary if delivery or settlement is not possible within CREST within the timetable set out in this announcement or would not be consistent with the regulatory requirements in the jurisdictions of such Placee. It is expected that settlement of the Placing will be on 8 October 2007. Interest is chargeable daily on payments not received from Placees on the due date in accordance with the arrangements set out in this Appendix at the rate of 2 per cent. above the base rate from time to time of Barclays Bank Plc. If a Placee does not comply with these obligations, either (i) DKS and/or DBAG, and/or (ii) Arbuthnot (as appropriate) may sell the Fully Paid Rights allocated to such Placee and retain from the proceeds, an amount equal to the Placing Price multiplied by the number of Fully Paid Rights comprised in its Placing Commitment, plus any interest due. The relevant Placee will, however, remain liable, inter alia, for any shortfall below the Placing Price and it may be required to bear any stamp duty or stamp duty reserve tax (together with any interest or penalties) which may arise upon the sale of its Fully Paid Rights on its behalf. If Fully Paid Rights are to be delivered to a custodian or settlement agent of a Placee, the relevant Placee should ensure that its Confirmed Commitment Letter is copied and delivered immediately to the relevant person within that organisation. Placees will be required to pay UK stamp duty or stamp duty reserve tax (as appropriate) on the aggregate value of their Placing Commitment at the Placing Price. Representations and Warranties by Placees By participating in the Placing, each Placee (and any persons acting on its behalf): 1. represents and warrants that it is entitled to subscribe for and purchase Fully Paid Rights and the related New Ordinary Shares under the laws of all relevant jurisdictions which apply to it and that it has fully observed such laws and obtained all such governmental and other guarantees and other consents which may be required there under and complied with all necessary formalities; 2. represents and warrants that the issue to the Placee, or the person specified by such Placee for registration as holder of Fully Paid Rights and the related New Ordinary Shares will not give rise to a liability under any of sections 67, 70, 93 or 96 of the Finance Act 1986 (depositary receipts and clearance services); 3. represents and warrants that it has complied with its obligations in connection with money laundering under the Criminal Justice Act 1993, the Money Laundering Regulations 1993 and the Money Laundering Regulations 2003 (together, the 'Regulations') and, if it is making payment on behalf of a third party, that satisfactory evidence has been obtained and recorded by it to verify the identity of the third party as required by the Regulations; 4. represents and warrants that it is a person falling within Article 19 (5) or Article 49(2) (a) to (d) of the Order and undertakes that it will acquire, hold, manage or dispose of any Fully Paid Rights and the related New Ordinary Shares that are allocated to it for the purposes of its business; 5. represents and warrants that it has complied and will comply with all applicable provisions of FSMA with respect to anything done by it in relation to the Fully Paid Rights and the related New Ordinary Shares in, from or otherwise involving the United Kingdom; 6. represents and warrants that it has all necessary capacity and authority and has obtained all necessary consents and authorities to enable it to commit to participation in the Placing and to perform its obligations in relation thereto and will honour its obligations (including, without limitation, in the case of any person on whose behalf it is acting, all necessary consents and authorities to agree to the terms set out or referred to in this announcement); 7. undertakes that it will pay for the Fully Paid Rights and the related New Ordinary Shares acquired by it in accordance with this Appendix on the due time and date set out herein, failing which the relevant Fully Paid Rights or, if appropriate, the related New Ordinary Shares may be placed with other subscribers or sold as either (i) DKS and/or DBAG, and/or (ii) Arbuthnot determine and without liability to such Placee; 8. acknowledges that participation in the Placing is on the basis that it is not and will not be a client or customer of DKS, DBAG or Arbuthnot and that DKS, DBAG and Arbuthnot have no duties or responsibilities to it for providing the protections afforded to their respective clients or customers or for providing advice in relation to the Placing or in respect of any representations, warranties, undertakings or indemnities contained in the Underwriting Agreement nor for the exercise or performance of any of DBAG's or Arbuthnot's rights and obligations thereunder, including any right to waive or vary conditions or exercise any termination right; 9. undertakes and agrees that (i) the person whom it specifies for registration as holder of the Fully Paid Rights and the related New Ordinary Shares will be (a) the Placee or (b) a nominee of the Placee, (ii) none of DKS, DBAG, Arbuthnot nor the Company will be responsible for any additional liability to stamp duty or stamp duty reserve tax resulting from a failure to observe this requirement and (iii) the Placee and any person acting on its behalf agrees to acquire Fully Paid Rights and the related New Ordinary Shares on the basis that the same will be allotted to the CREST stock account of DKS who, in respect of Placees procured by DKS, will hold them as nominee on its behalf until settlement in accordance with its standing settlement instructions and, in respect of Placees procured by Arbuthnot, will hold them as nominee and then transfer them to Arbuthnot on its behalf until Arbuthnot undertakes settlement in accordance with its standing settlement instructions; 10. acknowledges that any agreements entered into by it pursuant to these terms and conditions shall be governed by and construed in accordance with the laws of England and that it submits (on behalf of itself and on behalf of any person on whose behalf it is acting) to the exclusive jurisdiction of the English courts as regards any claim, dispute or matter arising out of any such contract; 11. acknowledges that the Fully Paid Rights and the related Nil Paid Rights and New Ordinary Shares have not been and will not be registered under the securities legislation of any state of the United States, Canada, France, Japan, Malaysia, New Zealand, South Africa or Switzerland and, subject to certain exceptions, may not be offered, sold, delivered or transferred, directly or indirectly, within those jurisdictions; 12. undertakes and agrees that neither it nor any of its affiliates (as defined in Rule 501(b) of the Securities Act) nor any person acting on its or their behalf will offer or sell any Fully Paid Rights and the related New Ordinary Shares within the United States except in accordance with Rule 903 of Regulation S of the Securities Act or to QIBs pursuant to the exemption from the registration requirements of the Securities Act provided by Rule 144A; 13. undertakes and agrees that neither it nor its affiliates (as defined in Rule 501(b) of the Securities Act) nor any person acting on its or their behalf have engaged in or will engage in any 'general solicitation or general advertising' (within the meaning of Regulation D under the Securities Act) or 'directed selling efforts' (as defined in Regulation S under the Securities Act) in connection with any offer or sale of the Fully Paid Rights and the related New Ordinary Shares; 14. acknowledges that stamp duty and stamp duty reserve tax is payable in respect of each Placee's commitment (and/or the commitment of a person for whom it is contracting as agent) and that the Placee is solely responsible for payment of the same and none of Daedalus, the Company, DKS, DBAG and Arbuthnot will be responsible for its payment. In addition, Placees should note that they will be liable for any capital duty, stamp duty and all other stamp, issue, securities, transfer, registration, documentary or other duties or taxes (including any interest, fines or penalties relating thereto) payable outside the UK by them or any other person on the acquisition by them of any Fully Paid Rights and the related New Ordinary Shares or the agreement by them to acquire any Fully Paid Rights and the related New Ordinary Shares; 15. acknowledges that any monies of any Placee or any person acting on behalf of the Placee held or received by DKS or Arbuthnot will not be subject to the protections conferred by the FSA's Client Money Rules. As a consequence, these monies will not be segregated from the monies of DKS or Arbuthnot and may be used by DKS and/or Arbuthnot (as appropriate) in the course of their respective businesses, and the relevant Placee or any person acting on its behalf will therefore, to the extent it has a claim against DKS and/or Arbuthnot, rank as a general creditor of DKS and/or Arbuthnot (as appropriate); and 16. (i) acknowledges that its acceptance of such participation is not by way of acceptance of the public offer to be made in the Prospectus and Provisional Allotment Letters but is by way of a collateral contract and as such section 87Q of the FSMA does not entitle it to withdraw if the Company publishes a supplementary prospectus in connection with the Rights Issue; and (ii) irrevocably undertakes to each of DKS, DBAG, Arbuthnot and the Company that if at any time it becomes entitled pursuant to section 87Q of the FSMA to withdraw its Placing Commitment or otherwise not to acquire the Fully Paid Rights in the Placing upon the terms and conditions of this Appendix, it will forthwith re-confirm to both DKS and Arbuthnot its Placing Commitment on the terms in this Appendix by completing and returning to DKS or Arbuthnot (as appropriate, depending upon to which of DKS or Arbuthnot it previously returned a Form of Confirmation) a further Form of Comfirmation in respect of the full Placing Commitment referred to in the Form(s) of Confirmation returned by it before such withdrawal rights arose. 17. represents and warrants that it has read and understood this Appendix in its entirety and acknowledges that its participation in the Placing will be governed by the terms of this document and the U Proof. 18. agrees to indemnify on an after-tax basis and hold harmless the Company, DKS, DBAG and Arbuthnot, any of their respective Affiliates and any person acting on their behalf from any and all costs, claims, liabilities and expenses (including legal fees and expenses) arising out of or in connection with any breach of the representations, warranties, acknowledgements, agreements and undertakings in this Appendix and further agrees that the provisions of this Appendix shall survive after completion of the Rights Issue and the Placing; 19. acknowledges that the Existing Ordinary Shares are listed on the London Stock Exchange/Official List of the UK Listing Authority, and the Company is therefore required to publish certain business and financial information in accordance with the rules and practices of the London Stock Exchange/FSA (collectively, the 'Exchange Information'), which includes a description of the nature of the Company's business and the Company's most recent balance sheet and profit and loss account, and similar statements for preceding financial years, and that the Placee is able to obtain or access the Exchange Information without undue difficulty; 20. acknowledges that none of DBAG, DKS or Arbuthnot, nor any of their Affiliates nor any person acting on their behalf has provided, and will not provide it with any material or information regarding the New Ordinary Shares or the Company; nor has it requested DBAB, DKS or Arbuthnot, nor any of their Affiliates or any person acting on their behalf to provide it with any such material or information; 21. acknowledges that the content of this document is exclusively the responsibility of the Company and that none of DKS, DBAG nor Arbuthnot, nor any of their respective Affiliates nor any person acting on their behalf will be responsible for or shall have any liability for any information, representation or statement relating to the Company contained in the U Proof or this Appendix or any information previously published by or on behalf of the Company and none of DKS, DBAG or Arbuthnot any of their respective Affiliates nor any person acting on their behalf will be liable for any Placee's decision to participate in the Placing based on any information, representation or statement contained in the U Proof or this Appendix or otherwise. Each Placee further represents, warrants and agrees that the only information on which it is entitled to rely and on which such Placee has relied in committing to subscribe for the New Ordinary Shares is contained in the U Proof or this Appendix and any Exchange Information, such information being all that it deems necessary to make an investment decision in respect of the New Ordinary Shares, and that it has relied on its own investigation with respect to the New Ordinary Shares and the Company in connection with its decision to subscribe for the New Ordinary Shares and acknowledges that it is not relying on any investigation that DKS, DBAG, Arbuthnot any of their respective Affiliates or any person acting on their behalf may have conducted with respect to the New Ordinary Shares or the Company and none of such persons has made any representations to it, express or implied, with respect thereto; 22. acknowledges that it has not relied on any information relating to the Company contained in any research reports prepared by DKS, DGAB, Arbuthnot, any of their Affiliates or any person acting on DKS's, DBAG, Arbuthnot or any of their Affiliates' behalf and understands that (i) none of DKS, DGAB, Arbuthnot, any of their Affiliates nor any person acting on their behalf has or shall have any liability for public information or any representation; (ii) none of DKS, DGAB, Arbuthnot, any of their Affiliates nor any person acting on their behalf has or shall have any liability for any additional information that has otherwise been made available to such Placee, whether at the date of publication, the date of this document or otherwise; and that (iii) none of DKS, DGAB, Arbuthnot, any of their Affiliates nor any person acting on their behalf makes any representation or warranty, express or implied, as to the truth, accuracy or completeness of such information, whether at the date of publication, the date of this document or otherwise; 23. represents and warrants that it understands that the New Ordinary Shares have not been and will not be registered under the Securities Act or under the securities laws of any state or other jurisdiction of the United States and that the Company has not been registered as an 'investment company' under the United States Investment Company Act of 1940, as amended; 24. represents and warrants that it has not offered or sold and will not offer or sell any New Ordinary Shares to persons in the United Kingdom prior to Admission except to qualified investors as defined in section 86(7) of FSMA, being persons falling within Article 2.1(e)(i), (ii) or (iii) of the Prospectus Directive; 25. represents and warrants that it has only communicated or caused to be communicated and will only communicate or cause to be communicated any invitation or inducement to engage in investment activity (within the meaning of section 21 of FSMA) relating to the New Ordinary Shares in circumstances in which section 21(1) of FSMA does not require approval of the communication by an authorised person; 26. represents and warrants that it is a qualified investor as defined in section 86(7) of FSMA, being a person falling within Article 2.1(e)(i), (ii) or (iii) of the Prospectus Directive; 27. acknowledges that any of DKS, DBAG or Arbuthnot may itself become a Placee in respect of some or all of the New Ordinary Shares or nominate any connected or associated person to do so; 28. acknowledges that until 40 days after the Acceptance Date, an offer or sale of New Ordinary Shares within the United States by any dealer (whether or not participating in the Placing) may violate the registration requirements of the Securities Act if such offer or sale is made otherwise than in accordance with Rule 144A or pursuant to another exemption from registration under the Securities Act to a person that is a QP (as defined below); 29. that (a) it is a qualified institutional buyer within the meaning of Rule 144A of the Securities Act; (b) it is a 'qualified purchaser' within the meaning of Section 2(a)(51) of the United States Investment Company Act of 1940, as amended ('QP'), and is not (i) a broker or dealer which owns or invests less than US$25 million in securities of unaffiliated issuers; (ii) a participant-directed employee plan or (iii) formed for the purposes of investing in the New Ordinary Shares or the Company; (c) it has duly executed, or will duly execute, an investor letter in the form provided to it by DKS, DGAB or Arbuthnot in which it will make certain undertakings, representations and warranties in addition to those contained herein; and (d) it is subscribing for the New Ordinary Shares for its own account, or for the account managed on behalf of another QIB that is also a QP, and not with a view to any distribution within the meaning of the Securities Act or applicable state law except as set forth below; 30. it acknowledges and agrees that it has, or to the extent it is acquiring New Ordinary Shares for the account of another QIB, such other QIB (a) has, sufficient knowledge, sophistication and experience in financial and business matters so as to be capable of evaluating the merits and risks of the purchase of the New Ordinary Shares; (b) is able to bear the economic and financial risk (including a complete loss) of such a purchase; (c) has had sufficient time to consider and conduct its own investigation with respect to the offer and purchase of the New Ordinary Shares, including the tax, legal, currency and other economic considerations relevant to such investment and (d) will not look to the Company, DKS, DBAG, Arbuthnot any of their respective Affiliates or any person acting on their behalf for all or part of any such loss or losses it or they may suffer; 31. it acknowledges and agrees that the Company, DKS, DBAG and Arbuthnot, their respective Affiliates and any person acting on their behalf will rely upon its representations, warranties, undertakings, agreements and acknowledgements set forth herein and in the investor letter, and agrees to notify the Company, DKS, DBAG and Arbuthnot promptly in writing if any of its representations, warranties, undertakings, agreements or acknowledgements cease to be accurate and complete. The acknowledgements, undertakings, representations and warranties referred to above are given to each of the Company, DKS, DBAG and Arbuthnot (for their own benefit and, where relevant, the benefit of their respective Affiliates and any person acting on their behalf) and are irrevocable. No UK stamp duty or stamp duty reserve tax should be payable to the extent that the New Ordinary Shares are issued or transferred (as the case may be) into CREST to, or to the nominee of, a Placee who holds those shares beneficially (and not as agent or nominee for any other person) within CREST and registered in the name of such Placee or such Placee's nominee. Any arrangements to issue or transfer the New Ordinary Shares into a depositary receipts system or a clearance service or to hold the New Ordinary Shares as agent or nominee of a person to whom a depositary receipt may be issued or who will hold the New Ordinary Shares in a clearance service, or any arrangements subsequently to transfer the New Ordinary Shares, may give rise to stamp duty and/or stamp duty reserve tax, for which none of the Company, DKS, DBAG or Arbuthnot will be responsible and the Placee to whom (or on behalf of whom, or in respect of the person for whom it is participating in the Placing as an agent or nominee) the allocation, allotment, issue or delivery of New Ordinary Shares has given rise to such stamp duty or stamp duty reserve tax undertakes to pay such stamp duty or stamp duty reserve tax forthwith and to indemnify on an after-tax basis and to hold harmless the Company, DKS, DBAG and Arbuthnot in the event that any of the Company and/or DKS and/or DBAG and/or Arbuthnot has incurred any such liability to stamp duty or stamp duty reserve tax. In addition, Placees should note that they will be liable for any capital duty, stamp duty and all other stamp, issue, securities, transfer, registration, documentary or other duties or taxes (including any interest, fines or penalties relating thereto) payable outside the UK by them or any other person on the acquisition by them of any New Ordinary Shares or the agreement by them to acquire any New Ordinary Shares. All times and dates in this document may be subject to amendment. DKS or Arbuthnot will notify the Placees and any person acting on behalf of the Placees of any such changes. This document has been issued by the Company and is the sole responsibility of the Company. The rights and remedies of DKS, DBAG, Arbuthnot and the Company under these terms and conditions are in addition to any rights and remedies which would otherwise be available to each of them and the exercise or partial exercise or partial exercise of one will not prevent the exercise of others. Each Placee may be asked to disclose in writing or orally to DKS and/or Arbuthnot: (a) if he is an individual, his nationality; or (b) if he is a discretionary fund manager, the jurisdiction in which the funds are managed or owned. Dresdner Kleinwort Securities Limited, which is authorised and regulated by the Financial Services Authority, and Dresdner Bank AG, London Branch, which is authorised by BAFin and by the Financial Services Authority for the conduct of designated investment business in the United Kingdom, are acting for the Company and for no one else in connection with the Rights Issue and will not be responsible to anyone other than the Company for providing the protections afforded to customers of Dresdner Bank AG, London Branch and Dresdner Kleinwort Securities Limited or for providing advice in relation to the Rights Issue, or any other matters referred to herein. Arbuthnot Securities Limited, which is authorised and regulated by the Financial Services Authority, is acting for the Company and for no one else in connection with the Rights Issue and will not be responsible to anyone other than the Company for providing the protections afforded to customers of Arbuthnot Securities Limited or for providing advice in relation to the Rights Issue, or any other matters referred to herein. APPENDIX V GLOSSARY OF TERMS 'Acceptance Date' 25 October 2007 or such other date (not being later than 31 October 2007) as the Company and DBAG and Arbuthnot may agree 'Admission' admission of the New Ordinary Shares, nil paid, to the Official List and to trading on the main market for listed securities of the London Stock Exchange; 'Arbuthnot' Arbuthnot Securities Limited; 'Closing Price' the closing middle market quotation of an Existing Ordinary Share, as published in the Daily Official List; 'Commitment Period' the period commencing on (and including) the date of the Underwriting Agreement and ending on (and including) the earliest of: (a) if there are no Remaining Shares, 11.00 a.m. on the Acceptance Date; (b) if there are any Remaining Shares, 5.00 p.m. on the second Dealing Day following the Acceptance Date; (c) the date on which the obligations of the Underwriters lapse because any condition to the Underwriting Agreement becomes incapable of being fulfilled (and is not waived) or if all such conditions are not fulfilled (or waived); and (d) the date on which notice is given by the DBAG and Arbuthnot to the Company terminating their obligations under the Underwriting Agreement 'Committed Shares' the 72,485,851 Rights Shares in aggregate in respect of which Qualifying Shareholders have irrevocably undertaken to subscribe (or procure that their nominees subscribe) or, in the case of the Directors, have indicated their intention to subscribe or procure that their nominee(s) subscribe 'CREST' the system for the paperless settlement of trades in securities and the holding of uncertificated securities in accordance with the CRESTCo Regulations operated by CRESTCo; 'CRESTCo Regulations' the Uncertificated Securities Regulations 2001 (SI 2001 No. 3755), as amended form time to time; 'CRESTCo' Euroclear UK & Ireland Limited; 'Daedalus' Daedalus Projects Limited; 'Daily Official List' the daily official list of the London Stock Exchange; 'Dealing Day' a day upon which dealings in domestic securities may take place on and with the authority of the London Stock Exchange; 'DBAG' Dresdner Bank AG, London branch; 'EGM Date' 2 October 2007 'Enlarged Share Capital' the issued ordinary share capital of the Company following the issue of the New Ordinary Shares pursuant to the Rights Issue; 'Existing Facilities Agreements' the facility agreement dated 15 March 2004 (as amended) between the Company and The Royal Bank of Scotland plc acting as agent for National Westminster Bank plc as lender (the 'RBS Facility Agreement') and each of the Bank Facilities Agreements and Surety Facilities Agreements (each as defined in the RBS Facility Agreement as amended and restated by the Facilities Amendment Agreements) 'Existing Ordinary Shares' the ordinary shares of 5 pence each in the capital of the Company at the date of this document; 'Extraordinary General Meeting' the extraordinary general meeting of the Company to be convened pursuant to the notice set out at the end of this document (including any adjournment thereof); 'Facilities Amendment Agreements' the amendment and restatement agreements each dated on or about the date of this Agreement in the approved terms relating to the Existing Facilities Agreements 'Form of Confirmation' the form of confirmation in respect of the Placing or sub-underwriting participation, as the case may be 'FSMA' the Financial Services and Markets Act 2000 'Fully Paid Rights' rights to acquire New Ordinary Shares, fully paid; 'Kharafi' Mohammed Abdulmohsin Al-Kharafi & Sons WLL; 'London Stock Exchange' London Stock Exchange plc or its successor(s); 'New Facilities Agreements' the new facilities agreements to be entered into pursuant to the Facilities Amendment Agreements and those facilities described as 'New Surety Facilities Agreements' in the Facilities Amendment Agreements 'New Ordinary Shares' the ordinary shares of 5 pence each in the capital of the Company to be issued by the Company pursuant to the Rights Issue; 'Nil Paid Rights' the Rights Shares in nil paid form provisionally allotted to Qualifying Shareholders in connection with the Rights Issue 'Official List' the official list of the UK Listing Authority; 'Ordinary Shares' Existing Ordinary Shares and/or New Ordinary Shares, as the context requires; 'Placing' the sale of rights over 81,261,941 New Ordinary Shares on behalf of Daedalus; 'Prospectus' the document dated 14 September 2007, comprising a prospectus relating to the Company for the purpose of the Rights Issue and the listing of the New Ordinary Shares on the London Stock Exchange (together with any supplements or amendments thereto); 'Prospectus Directive' the EU Prospectus Directive 2003/71/EC 'Provisional Allotment Letter' the provisional allotment letter issued to Qualifying Non-CREST Shareholders; 'Qualifying Shareholders' holders of Existing Ordinary Shares on the register of members of the Company on the Record Date; 'Qualifying Non-CREST Qualifying Shareholders holding Ordinary Shares in certificated form; Shareholders' 'Record Date' the close of business in London on 28 September 2007; 'Remaining Shares' such number of the Underwritten Shares as are neither taken up nor deemed to be taken up 'Rights Issue' the offer by way of rights to Qualifying Shareholders to acquire New Ordinary Shares, on the terms and conditions set out in this document and, in the case of Qualifying Non-CREST Shareholders only, the Provisional Allotment Letter; 'Rights Issue Price' 24 pence per New Ordinary Share; 'Rights Shares' up to 267,923,469 new Ordinary Shares proposed to be allotted and offered for subscription under the Rights Issue 'Rule 144A' Rule 144A as promulgated under the Securities Act 'SEC' US Securities Exchange Commission 'Securities Act' Unites States Securities Act, 1933 (as amended) 'Shareholder(s)' holder(s) of Ordinary Shares; 'Stick' those Underwritten Shares that are not taken up or deemed to be taken up and that DKS and Arbuthnot do not procure persons to take up and so fall to be acquired by DBAG and/or Arbuthnot and/or the Sub-underwriters 'UEM Instruction Letter' the letter of instruction from Deadalus in connection with the Placing 'UKLA' the Financial Services Authority in its capacity as the United Kingdom Listing Authority 'Underwriters' Arbuthnot and DBAG; 'Underwriting Agreement' the conditional underwriting agreement; 'United Kingdom' or 'UK' the United Kingdom of Great Britain and Northern Ireland; 'United States' or 'US' the United States of America, its territories and possessions, any state of the United States and the District of Columbia. 'US Person' has the meaning ascribed to it under Regulation S under the Securities Act 'Undertakings' the Kharafi Undertaking and the UEM Undertaking 'Underwritten Shares' all the Rights Shares (including, for the avoidance of doubt only, the Daedalus shares to be Placed) other than the Committed Shares. Costain Group PLC Consolidated income statement Half-year ended 30 June, Notes 2007 2006 2006 year ended 31 December Half-year Half-year Year £m £m £m Revenue (Group and share of joint ventures 2 430.0 436.2 886.3 and associates) Share of joint ventures and associates 5 (77.7) (63.9) (137.9) Group revenue 352.3 372.3 748.4 Cost of sales (337.9) (385.9) (785.9) Gross profit/(loss) 14.4 (13.6) (37.5) Administrative expenses (10.8) (9.0) (20.9) Group operating profit/(loss) 3.6 (22.6) (58.4) Profit on sale of investment 2.7 - 3.6 Profit on sale of joint ventures and 0.2 3.5 - associates Amounts written off loans to associate - - (2.7) Share of results of joint ventures and 5 0.1 (2.8) (7.0) associates Profit/(loss) from operations 2 6.6 (21.9) (64.5) Financial income 3 14.5 13.2 26.7 Finance costs 3 (13.1) (12.0) (23.9) Net financing income 1.4 1.2 2.8 Profit/(loss) before tax 8.0 (20.7) (61.7) Income tax (expense)/credit (1.8) 2.6 7.7 Profit/(loss) for the period attributable 2 6.2 (18.1) (54.0) to equity holders of the parent Earnings/(loss) per share - basic 4 1.7p (5.1)p (15.1)p Earnings/(loss) per share - diluted 4 1.7p (5.1)p (15.1)p Consolidated statement of recognised income and expense Half-year ended 30 June, 2007 2006 2006 year ended 31 December Half-year Half-year Year £m £m £m Exchange differences on translation of foreign operations - 0.3 - Cash flow hedges: Effective portion of changes in fair value (net of tax) during period - Group - 0.1 0.3 Effective portion of changes in fair value (net of tax) during period - joint ventures and associates 5.9 3.2 3.1 Change in fair value of assets classified as available for sale (2.6) (3.4) (0.8) Actuarial gains on defined benefit pension schemes 27.8 30.0 26.0 Tax recognised on actuarial gains recognised directly in equity (7.8) (9.0) (7.8) Tax rate adjustment to brought forward actuarial losses recognised directly in equity (1.7) - - Net income recognised directly in equity 21.6 21.2 20.8 Profit/(loss) for the period 6.2 (18.1) (54.0) Total recognised income and expense for the period 27.8 3.1 (33.2) attributable to equity holders of the parent Consolidated balance sheet Half-year ended 30 June, Notes 2007 2006 2006 year ended 31 December Half-year Half-year Year £m £m £m Assets Non-current assets Property, plant & equipment 4.4 5.8 5.7 Intangible assets 3.1 3.9 3.4 Investments in joint ventures 5 28.0 27.1 25.0 Investments in associates 5 2.9 1.0 1.2 Loans to joint ventures 4.3 2.6 3.3 Loans to associates 1.2 0.4 2.0 Other investments - 1.0 3.6 Other debtors 6.2 7.3 10.1 Deferred tax assets 18.4 24.6 30.6 Total non-current assets 68.5 73.7 84.9 Current assets Inventories 1.7 2.0 2.4 Trade and other receivables 146.0 184.3 160.6 Cash and cash equivalents 42.9 51.2 56.4 Total current assets 190.6 237.5 219.4 Total assets 259.1 311.2 304.3 Equity Share capital 17.9 17.9 17.9 Share premium 0.6 0.5 0.6 Special reserve 12.8 12.9 12.8 Fair value reserve - - 2.6 Foreign currency translation reserve (1.2) (0.9) (1.2) Hedging reserve 4.4 (1.7) (1.6) Retained earnings (61.7) (47.8) (86.3) Total equity attributable to equity (27.2) (19.1) (55.2) holders of the parent Minority interests - - - Total equity (27.2) (19.1) (55.2) Liabilities Non-current liabilities Interest bearing loans and borrowings - 0.1 - Retirement benefit obligations 38.4 69.5 68.7 Other payables 3.2 2.4 6.6 Provisions 3.4 4.9 4.1 Total non-current liabilities 45.0 76.9 79.4 Current liabilities Trade and other payables 233.6 243.4 266.1 Tax liabilities 1.8 3.2 2.7 Overdrafts 0.5 0.2 1.4 Interest bearing loans and borrowings 0.3 1.0 1.7 Provisions 5.1 5.6 8.2 Total current liabilities 241.3 253.4 280.1 Total liabilities 286.3 330.3 359.5 Total equity and liabilities 259.1 311.2 304.3 Consolidated cash flow statement Half-year ended 30 June, 2007 2006 2006 year ended 31 December Half-year Half-year Year £m £m £m Cash flows from operating activities Profit/(loss) for the period 6.2 (18.1) (54.0) Adjustments for: Depreciation and amortisation 1.1 1.2 2.7 Financial income (14.5) (13.2) (26.7) Finance costs 13.1 12.0 23.9 Share-based payments expense 0.2 0.2 0.3 Income tax 1.8 (2.6) (7.7) Profit on sale of investment (2.7) - (3.6) Profit on sale of interests in joint venture and associates (0.2) (3.5) - Share of results of joint ventures and associates (0.1) 2.8 7.0 Amounts written off loans to associates - - 2.7 Operating profit/(loss) before changes in working capital 4.9 (21.2) (55.4) and provisions Decrease/(increase) in inventories 0.7 - (0.4) Decrease/(increase) in receivables 18.4 (14.2) 2.2 (Decrease)/increase in payables (32.5) 5.3 32.6 Movement in provisions and employee benefits (6.1) (1.4) (2.6) Cash used by operations (14.6) (31.5) (23.6) Interest paid (0.1) (0.2) (0.3) Income taxes paid - - (0.2) Net cash used by operating activities (14.7) (31.7) (24.1) Cash flows from investing activities Interest received 1.2 1.2 2.6 Additions to property, plant & equipment (0.2) (0.7) (1.9) Additions to intangible assets (0.1) (0.8) (0.9) Proceeds from sale of fixed assets - - 0.2 Additions to investments - (2.0) (0.1) Disposal of subsidiary and associate (1.4) - - Proceeds from sale of investments 3.7 7.1 7.1 Dividend received from joint venture - 2.6 6.1 Loans to joint ventures and associates 0.3 0.2 (10.2) Net cash from investing activities 3.5 7.6 2.9 Cash flows from financing activities Issue of ordinary share capital - 0.2 0.3 New loans - 0.2 0.9 Payment of loans and finance lease liabilities (1.4) (0.1) (0.2) Net cash (used by)/from financing activities (1.4) 0.3 1.0 Net decrease in cash and cash equivalents (12.6) (23.8) (20.2) Cash and cash equivalents at beginning of period 55.0 75.0 75.0 Effect of foreign exchange rate changes - (0.2) 0.2 Cash and cash equivalents at end of period 42.4 51.0 55.0 Notes to the Interim Financial Statements These interim financial statements do not constitute statutory accounts within the meaning of the Companies Act 1985 and are unaudited. The Board approved the unaudited interim financial statements on 13 September 2007. 1. Basis of preparation This interim financial information has been prepared applying the accounting policies and presentation that were applied in the preparation of the company's published consolidated financial statements for the year ended 31 December 2006. They are prepared on a going concern basis. 2. Business and geographical segment information by origin In the opinion of the directors, the business segments are Civil Engineering, Building, Oil Gas & Process and International, which undertake engineering and construction projects, Property Development operations in Spain and Central Costs. These represent the Group's primary segments. Secondary segments are presented geographically. * Revenue in the tables below includes the Group's share of joint ventures and associates. For the half-year Civil Building Oil, Gas International Property Central Total ended Engineering & Process Development Costs 30 June 2007 £m £m £m £m £m £m £m Revenue * 280.4 108.5 26.2 13.0 1.9 - 430.0 Group operating profit 9.9 (3.3) - (0.2) - (2.8) 3.6 /(loss) Profit on sale of - 2.7 - - - - 2.7 investment Profit on sale of - - - 0.2 - - 0.2 associate Share of results of 0.2 0.2 0.2 - (0.5) - 0.1 joint ventures and associates Segment result 10.1 (0.4) 0.2 - (0.5) (2.8) 6.6 Net financing income 1.4 Income tax expense (1.8) Profit for the period 6.2 2. Business and geographical segment information by origin continued For the half-year Civil Building Oil, Gas & International Property Central Total ended Engineering Process Development Costs 30 June 2006 £m £m £m £m £m £m £m Revenue * 217.0 158.3 30.8 22.9 7.2 - 436.2 Group operating profit 7.5 (11.5) (1.2) (14.6) - (2.8) (22.6) /(loss) Profit on sale of - 3.5 - - - - 3.5 investment Share of results of 0.4 0.1 0.1 (5.5) 2.1 - (2.8) joint ventures and associates Segment result 7.9 (7.9) (1.1) (20.1) 2.1 (2.8) (21.9) Net financing income 1.2 Income tax credit 2.6 Loss for the period (18.1) For the year ended Civil Building Oil, Gas & International Property Central Total 31 December 2006 Engineering Process Development Costs £m £m £m £m £m £m £m Revenue * 488.1 298.0 57.2 29.8 13.2 - 886.3 Group operating profit 10.0 (29.6) (19.8) (13.0) - (6.0) (58.4) /(loss) Profit on sale of - 3.6 - - - - 3.6 investment Amounts written off - - - (2.7) - - (2.7) loans to associate Share of results of 0.3 0.1 0.3 (11.6) 3.9 - (7.0) joint ventures and associates Segment result 10.3 (25.9) (19.5) (27.3) 3.9 (6.0) (64.5) Net financing income 2.8 Income tax credit 7.7 Loss for the period (54.0) Revenue * Segment result 2007 2006 2006 2007 2006 2006 Half-year Half-year Year Half-year Half-year Year £m £m £m £m £m £m United Kingdom 405.7 390.6 816.9 7.2 (4.4) (22.1) Spain 1.9 7.2 13.2 (0.5) 2.1 3.9 Rest of the world 22.4 38.4 56.2 (0.1) (19.6) (46.3) 430.0 436.2 886.3 6.6 (21.9) (64.5) 3. Net financing income/(costs) Finance income includes the expected return on the assets of the pension scheme of £13.4m (2006 half-year £12.0m, 2006 year £24.1m) and finance costs include the expected increase in the present value of the pension scheme liabilities of £12.9m (2006 half-year £11.9m, 2006 year £23.6m). The expected return and the increase in present value are based on the value of assets and liabilities of the pension scheme at the start of the period. 4. Earnings/(loss) per share The calculation of earnings/(loss) per share is based on profit for the period of £6.2m (2006 half-year loss £18.1m, 2006 year loss £54.0m) and the number of shares set out below: 2007 2006 2006 Half-year Half-year Year Weighted average number of shares for basic earnings per 357,231,292 356,875,207 357,050,423 share calculation Dilutive potential ordinary shares: SAYE Scheme 5,772,679 6,567,096 6,314,913 Weighted average number of shares for fully diluted 363,003,971 363,442,303 363,365,336 earnings per share calculation 5. Joint ventures and associates The analysis of the Group's share of joint ventures (JVs) and associates is set out below: 2007 Half-year Alcaidesa 4Delivery Ltd Other joint Holding SA ventures Associates Total £m £m £m £m £m Revenue 1.9 53.3 18.2 4.3 77.7 (Loss)/profit before tax (0.7) - 0.4 0.4 0.1 Income tax credit/(expense) 0.2 - (0.1) (0.1) - (Loss)/profit for the period (0.5) - 0.3 0.3 0.1 Non-current assets 7.1 - 6.6 0.3 14.0 Current assets 27.9 60.8 90.5 51.2 230.4 Current liabilities (4.1) (60.7) (14.3) (1.3) (80.4) Non-current liabilities (7.4) - (78.4) (47.3) (133.1) Investments in joint ventures and associates 23.5 0.1 4.4 2.9 30.9 Presentation in the balance sheet in respect of joint ventures and associates restricts the minimum carrying value to £nil. If the carrying value becomes negative, the corresponding value of any loans or other advances to those investments is reduced or, where future funding obligations exist, a provision is made. 5. Joint ventures and associates continued 2006 Half-year Alcaidesa 4Delivery Ltd Other joint Holding SA ventures Associates Total £m £m £m £m £m Revenue 7.2 33.4 19.2 4.1 63.9 Profit/(loss) before tax 3.1 0.1 (4.5) (0.5) (1.8) Income tax expense (1.0) - - - (1.0) Profit/(loss) for the period 2.1 0.1 (4.5) (0.5) (2.8) Non-current assets 6.5 - 5.2 1.9 13.6 Current assets 41.3 13.4 49.2 48.6 152.5 Current liabilities (18.1) (13.3) (13.3) (7.4) (52.1) Non-current liabilities (3.5) - (40.3) (42.1) (85.9) Investments in joint ventures and associates 26.2 0.1 0.8 1.0 28.1 2006 year Alcaidesa 4Delivery Ltd Other joint Holding SA ventures Associates Total £m £m £m £m £m Revenue 13.2 84.6 26.5 13.6 137.9 Profit/(loss) before tax 6.1 - (10.9) 0.1 (4.7) Income tax expense (2.2) - (0.1) - (2.3) Profit/(loss) for the period 3.9 - (11.0) 0.1 (7.0) Non-current assets 5.7 - 7.2 2.4 15.3 Current assets 33.6 25.1 82.1 51.4 192.2 Current liabilities (8.1) (25.1) (20.0) (12.9) (66.1) Non-current liabilities (7.3) - (68.2) (39.7) (115.2) Investments in joint ventures and associates 23.9 - 1.1 1.2 26.2 2007 2006 2006 Half-year Half-year Year £m £m £m Financial commitments 11.3 10.3 9.3 Capital commitments 29.6 28.4 25.1 The commitments relate to joint ventures involved in Private Finance Initiative schemes and the capital commitments to construction work being undertaken by the Costain Group. All figures are the Group's share. The comparative figures for the financial year ended 31 December 2006 are not the Company's statutory accounts for that financial year. Those accounts have been reported on by the Company's auditors and delivered to the Registrar of Companies. The report of the auditors was (i) unqualified, (ii) did not include a reference to any matters to which the auditors drew attention by way of emphasis without qualifying their report, and (iii) did not contain a statement under section 237(2) or (3) of the Companies Act 1985. The Interim Report and Accounts are unaudited but have been reviewed by the Company's auditors and their Independent Review Report is set out below. INDEPENDENT REVIEW REPORT TO COSTAIN GROUP PLC Introduction We have been instructed by the Company to review the financial information for the six months ended 30 June 2007 which comprises Consolidated Income Statement, Consolidated Statement of Recognised Income and Expense, Consolidated Balance Sheet, Consolidated Cash Flow Statement and the related notes. We have read the other information contained in the interim report and considered whether it contains any apparent misstatements or material inconsistencies with the financial information. This report is made solely to the Company in accordance with the terms of our engagement to assist the Company in meeting the requirements of the Listing Rules of the Financial Services Authority. Our review has been undertaken so that we might state to the Company those matters we are required to state to it in this report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company for our review work, for this report, or for the conclusions we have reached. Directors' responsibilities The interim report, including the financial information contained therein, is the responsibility of, and has been approved by, the directors. The directors are responsible for preparing the interim report in accordance with the Listing Rules of the Financial Services Authority which require that the accounting policies and presentation applied to the interim figures should be consistent with those applied in preparing the preceding annual accounts except where any changes, and the reasons for them, are disclosed. Review work performed We conducted our review in accordance with guidance contained in Bulletin 1999/ 4: Review of interim financial information issued by the Auditing Practices Board for use in the UK. A review consists principally of making enquiries of management and applying analytical procedures to the financial information and underlying financial data and, based thereon, assessing whether the accounting policies and presentation have been consistently applied unless otherwise disclosed. A review excludes audit procedures such as tests of controls and verification of assets, liabilities and transactions. It is substantially less in scope than an audit performed in accordance with International Standards on Auditing (UK and Ireland) and therefore provides a lower level of assurance than an audit. Accordingly, we do not express an audit opinion on the financial information. Review conclusion On the basis of our review we are not aware of any material modifications that should be made to the financial information as presented for the six months ended 30 June 2007. KPMG Audit Plc Chartered Accountants London 13 September 2007 UNSOLICITED MAIL The Company is legally obliged to make its share register available to the general public. Consequently some shareholders may receive unsolicited mail, including correspondence from unauthorised investment firms. Shareholders who wish to limit the amount of unsolicited mail they receive can contact: The Mailing Preference Service Freepost (LON 20771) London WE1 0ZT SHAREHOLDER INFORMATION The Company's Registrar is Lloyds TSB Registrars, The Causeway, Worthing, West Sussex BN99 6DA. Their web site address is www.lloydstsb-registrars.co.uk. For enquiries regarding your shareholding, please telephone 0870 600 3984. You can also view up-to-date information about your holdings by visiting the shareholder web site at www.shareview.co.uk. Please ensure that you advise Lloyds TSB Registrars promptly of a change of name or address. ShareGIFT The Orr Mackintosh Foundation (ShareGIFT) operates a charity share donation scheme for shareholders with small parcels of shares whose value makes it uneconomic to sell them. Details of the scheme are available on the ShareGIFT Internet Site www.sharegift.org. Lloyds TSB Registrars can provide stock transfer forms on request. Donating shares to charity in this way gives rise neither to a gain nor a loss for Capital Gains Tax purposes. This service is completely free of charge. This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings